Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective ...
"As a leader in computational drug discovery, Schrödinger is pleased to partner with Lilly TuneLab," stated Pat Lorton, chief technology officer and chief operating officer, software at Schrödinger.
Market conditions remain tough, which is weighing on demand for both Schrödinger's software and drug discovery services. Investors continue to punish Schrödinger's investments in drug discovery, ...
Eli Lilly has joined Schrödinger’s growing stable of drug development partners, putting up $425 million in milestones to access small-molecule candidates against an undisclosed target. Schrödinger has ...
A group of modern physicists released a YouTube video starring the internet's favourite animal to explain Erwin Schrödinger's famous thought experiment for his 127th birthday. Born in 1887, ...
Schrödinger's Q4 2024 results and 2025 guidance were solid, yet the company's share price remains low due to ongoing losses. Cash burn is likely to moderate going forward, as investments in the ...
Receive emails about upcoming NOVA programs and related content, as well as featured reporting about current events through a science lens. That may come as a surprise to those who associate ...
Inside a box, there is a cat. It may be dead or it may be alive, because also in that small space is a vial of poisonous gas that has a 50/50 chance of releasing its destruction upon kitty. But no one ...
Erwin Schrödinger was the only son of well-educated parents. His father owned an oil cloth factory and was an amateur painter and botanist. Erwin was taught at home, by tutors and parents, until he ...
Schrödinger (SDGR) on Friday announced a collaboration with Eli Lilly (LLY) to integrate its drug development software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results